DYSLIPIDEMIA: OVERVIEW OF THE ESC/EAS 2019 RECOMMENDATIONS FOR DIAGNOSTICS AND TREATMENT. PART 2 – TARGET THERAPY
Journal: Journal of the Grodno State Medical University (Vol.19, No. 2)Publication Date: 2021-05-20
Authors : V. M. Pyrochkin Y. I. Karpovich E. V. Mironchik A. V. Kovtun;
Page : 236-241
Keywords : cardiovascular disease; cardiovascular risk; dyslipidemia; pharmacotherapy;
Abstract
The high incidence of cardiovascular disease leads to a routine individual assessment of the patient's cardiovascular risk, and to the correction of the therapy. In 2019, at the European Congress of Cardiology, updated recommendations of the ESC/EAS (European Society of Cardiology / European Atherosclerosis Society) on the diagnosis and treatment of dyslipidemia were presented, new approaches to cardiovascular risk assessing and correction of dyslipidemia were formulated. The article discusses the main aspects of clinical application of the new recommendations for the treatment of this pathology.
Other Latest Articles
- CLINICAL CASE OF ALLERGIC ACUTE CORONARY SYNDROME (KOUNIS SYNDROME) CAUSED BY COLD URTICARIA
- ALGORITHM FOR STRATIFICATION OF CARDIOVASCULAR RISK IN MEN AGED 18-29 YEARS WITH ARTERIAL HYPERTENSION SYNDROME
- THE USE OF NEW PHYSICAL COMPONENTS FOR SECONDARY AND TERTIARY PREVENTION OF THE DEVELOPMENT OF FALLS SYNDROME IN OLDER PERSONS
- CHANGES IN IMMUNITY PARAMETERS DURING RADIОTHERAPY FOR HEAD AND NECK CANCER DEPENDING ON THE METHOD OF RADIATION TOXICITY PREVENTION
- THE METHOD OF ASSESSING SOCIAL COMPLIANCE AS A FORM OF SOCIAL RESPONSIBILITY OF THE PATIENT
Last modified: 2021-05-20 20:47:03